| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2016↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $32.8B | $28.2B | $25.1B | $22.2B | $18.9B | $15.3B | $4.4B | $2.8B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $18.9B | $15.6B | $14.0B | $12.3B | $10.1B | $8.1B | $2.4B | $1.4B |
| Net Income | $15.0B | $12.9B | $11.2B | $9.9B | $8.7B | $6.4B | $2.1B | $0.9B |
| EPS (Basic) | $16.54 | $13.91 | $11.86 | $10.26 | $8.79 | $6.40 | $2.08 | $0.86 |
| EPS (Diluted) | $16.52 | $13.89 | $11.83 | $10.22 | $8.76 | $6.37 | $2.07 | $0.86 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2016↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $54.2B | $48.1B | $42.4B | $38.7B | $37.7B | $33.6B | $29.2B | $18.7B |
| Current Assets | $23.6B | $19.7B | $19.0B | $16.6B | $16.9B | $19.1B | $16.9B | $13.2B |
| Cash & Equivalents | $10.6B | $8.4B | $8.6B | $7.0B | $7.4B | $10.1B | $7.0B | $6.7B |
| Total Liabilities | $46.4B | $41.6B | $35.5B | $32.3B | $30.3B | $27.1B | $23.2B | $13.0B |
| Current Liabilities | $22.8B | $19.2B | $16.3B | $14.2B | $13.2B | $11.8B | $11.9B | $7.2B |
| Stockholders' Equity | $7.7B | $6.5B | $6.9B | $6.3B | $7.3B | $6.4B | $5.9B | $5.7B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2016↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $17.6B | $14.8B | $12.0B | $11.2B | $9.5B | $7.2B | $8.2B | $4.5B |
| Investing Cash Flow | $-1.4B | $-3.4B | $-1.4B | $-1.5B | $-5.3B | $-1.9B | $-1.6B | $-1.2B |
| Capital Expenditures | $0.5B | $0.5B | $0.4B | $0.4B | $0.4B | $0.3B | $0.4B | $0.2B |
| Financing Cash Flow | $-14.2B | $-10.8B | $-9.5B | $-10.3B | $-6.6B | $-2.2B | $-5.9B | $-2.3B |